Press Room

suPAR Poster wins prize at ESC2015

Denmark, September 3, 2015.

MD Gethin Hodges from Glostrup Hospital, Denmark, was elected for a moderated poster presentation at the ESC Congress 2015, European Society of Cardiology in London, with his poster titled;

"suPAR is Associated with Cardiovascular Events and Mortality in Patients with Asymptomatic Aortic Stenosis".

His poster on suPAR and CVD was awarded with the prize "Best Moderated Poster" in his session!

Also read the abstract on the newly published article by Gethin Hodges in CJC, Canadian Journal of Cardiology, with the title; "suPAR: A New Biomarker for Cardiovascular Disease?"


DSKB Nyt - suPAR is a new Prognostic Biomarker in Clinical Routine

Denmark, September 1, 2015.

In the latest issue of DSKB Nyt no. 2/2015, Dansk Selskab for Klinisk Biokemi, is an article on suPAR - a new prognostic biomarker in clinical routine at Copenhagen University Hospital, Hvidovre, Denmark.

suPAR has since november 2013 been measured on all patients upon admission to the Emergency Department at Hvidovre Hospital using the suPARnostic® AUTO Flex Elisa assay, automated on the BEP2000 platform and analysed once every day. Preliminary results show, that suPAR is strongly correlated with mortality (30- and 90-days), and that suPAR kan help identify the patients at risk who should receive increased clinical attention.

In order for clinicians at the Emergency Department to be able to use the suPAR results even better in the clinical assessment of the patient, they need to receive the suPAR results faster, together with other test results taken.

Hvidovre Hospitals Clinical Biochemical Department is therefore working on developing a new suPAR immunoturbidimetry assay on the COBAS 6000, to bring down the analysis time.

More information in the article (in Danish) here;
"Indførelse af suPAR som ny prognostisk biomarkør i klinisk rutine"

suPAR and CVD Poster Presentation at ESC 2015 in London

Denmark, August 10, 2015.

Come and hear the poster presentation about suPAR and CVD by MD Gethin Hodges (Glostrup Hospital, Denmark) at the ESC2015 Conference (European Society of Cardiology) in London, August 29 - September 2.

The title is; "suPAR is associated with cardiovascular events and mortality in patients with asymptomatic aortic stenosis"

The moderated poster presentation will take place on August 31 at 16.12 in the poster area, session number 335.

Also read the abstract on the newly published article by Gethin Hodges in CJC, Canadian Journal of Cardiology, with the title; "suPAR: A New Biomarker for Cardiovascular Disease?"

Please find the abstract in PubMed here;  suPAR: A New Biomarker for Cardiovascular Disease?

NEW - Quantitative suPARnostic® Quick Triage Point of Care Test

Denmark, June 15, 2015.

The suPARnostic® Quick Triage is now a fully Quantitative Test for suPAR levels between
2-16 ng/mL suPAR.

The quantitative results are read with the suPARnostic® Quick Test Reader – available in only
20 minutes.

The Quantitative suPARnostic® Quick Triage:
•       Facilitates better triage in the Emergency Room
•       Does not require highly skilled technician time or alter routines in the clinical laboratory
•       Can easily be done by a clinician in the Emergency Room

Each kit contains 25 units and ready-to-use buffer solution.

suPARnostic® Quick Triage is a Quantitative Point of Care Prognostic Triage test – delivering results in 20 minutes, giving the clinician a faster patient prognosis and an aid for prioritizing patients with unclear signs and history.

Please find more information on the Quantitative suPARnostic® Quick Triage Point of Care Test here; suPARnostic® Quick Triage

Join us at 1st Nordic suPAR Symposium in Helsinki

Denmark, May 28, 2015.

In collaboration with Prof. Dr. Maaret Castrén as host and Helsinki University Hospital (HUCH), ViroGates & Electrabox invite you to attend:

1st Nordic suPAR Symposium with the title; New Horizons in Emergency Department Assessments

The one-day meeting will take place on June 2nd 2015 from 10:00 to 17:00 at Meilahti Hospital in Helsinki.

The programme includes the following topics;

- Prognostic Triage Parameters in the Emergency Room
- Pre-hospital suPAR Risk Prognosis
- Economic Impacts of suPAR Implementations in the Emergency Department
- Risk Prognosis in Selected Diseases and in the General Population

Please find more information on the Symposium here; 1st Nordic suPAR Symposium


Contact us

virogates logo2
Blokken 45

3460 Birkerød

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033

 in-2  tw-2